To share your story, or find out how to get involved with CNBC Cures, email CNBC.cures@cnbc.com The growth of China's biotechnology sector has been staggering. Beijing is pumping money into the industry, backing research efforts and helping launch a new wave of labs and incubators in the country. That's a problem for the U.S. biotech industry and also affects rare disease patients who are waiting for a cure. Among the experts speaking out against China's growing influence in the biotech sector